Drug recall · July 31, 2019
Temozolomide Capsules recall
Why: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
- Lots / codes
Lot #: a) A063581, A063462, A063460, Exp 09/30/2019; A063582, Exp 10/31/2019; A069129, Exp 05/31/2020; A071801, Exp 09/30/2020; b) A063639, A063624, A063609, Exp 09/30/2019; A063657, Exp 10/31/2019; A069366, Exp 05/31/2020; A071817, A071819, A071818, Exp 09/30/2020
- Quantity
- a) 7380 bottles; b) 10332 bottles
- Company
- Deva Holding AS - Cerkezkoy Subesi, Cerkezkoy, N/A
- Distribution
- Nationwide in the USA.
- Initiated
- July 16, 2019 · Voluntary: Firm initiated
- Classified
- July 23, 2019
- Reported
- July 31, 2019
- Ended
- January 6, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temozolomide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.